Menu

Exterior shot of Biogen office

Biogen, GSK, Sobi and Amgen announced state exemptions from their 340B contract pharmacy and in-house pharmacy claims data restrictions.

Four Drugmakers Exempt New States From 340B Contract Pharmacy, In-House Claims Data Reqs.

August 18, 2026 Shannon Young, Managing Editor 340B Report Views

Three drugmakers recently exempted Illinois covered entities from their 340B contract pharmacy restrictions and in-house pharmacy claims data requirements, while [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

The Essential Role of a Location Crosswalk in 340B Program Management

Fed Judge Rules 11 Sagebrush-Linked Clinics Ineligible for 340B